An Endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells (2021)

First Author: Broadbent L

Attributed to: Repurposing FDA-Approved Drugs for Treatment of 2019-nCoV-induced Disease funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.08.17.456707

Publication URI: http://dx.doi.org/10.1101/2021.08.17.456707

Type: Preprint